FG
Distinguished in Overhydrated Hereditary Stomatocytosis
Check Dr. Fei Gu's experience treating your condition:
About Dr. Fei Gu

Fei Gu is a Hematologist Oncology specialist and a Hematologist in Santa Fe, New Mexico. Gu has been practicing medicine for over 32 years and is rated as a Distinguished expert by MediFind in the treatment of Overhydrated Hereditary Stomatocytosis. She is also highly rated in 30 other conditions, according to our data. Her top areas of expertise are D-Minus Hemolytic Uremic Syndrome, Dehydrated Hereditary Stomatocytosis, Overhydrated Hereditary Stomatocytosis, and Hemolytic Crisis. She is licensed to treat patients in Massachusetts. Gu is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Fei Gu it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
490a W Zia Rd, Santa Fe, NM 87505
Other Locations
3917 W Rd, Los Alamos, NM 87544
Background & Education
Graduate Institution
Other, 1990
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MA
Hospital Affiliations
CHRISTUS St Vincent Regional Medical Center
CHRISTUS Spohn Hospital Beeville
CHRISTUS Southeast Texas - St Elizabeth
CHRISTUS Santa Rosa Hospital - Medical Center
CHRISTUS Spohn Hospital Corpus Christi - Shoreline
Holy Cross Hospital
Los Alamos Medical Center
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Total Publications

Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Advanced
Advanced